RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hanmi Science Co Stock

Hanmi Science Co Stocks 2024

Hanmi Science Co Stocks

67.96 M

Ticker

008930.KS

ISIN

KR7008930000

In 2024, Hanmi Science Co had 67.96 M outstanding stocks, a -0.79% change from the 68.49 M stocks in the previous year.

The Hanmi Science Co Stocks history

YEARNUMBER OF STOCKS (undefined KRW)
202367.96
202268.49
202168.62
202066
201966
201866
201764
201666
201565
201469
201369
201266
201166
201054
200916
200817
200717
200618
200518
200418

Hanmi Science Co shares outstanding

The number of shares was Hanmi Science Co in 2023 — This indicates how many shares 67.956 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Hanmi Science Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Hanmi Science Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Hanmi Science Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Hanmi Science Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Hanmi Science Co Aktienanalyse

What does Hanmi Science Co do?

Hanmi Science Co Ltd is a South Korean company specializing in the manufacturing of pharmaceutical products, biologics, and medical devices. The company was founded in 1973 as a chemical company and obtained the license for drug manufacturing in 1990, expanding its product range to include pharmaceuticals. Today, the company's business model includes three main areas: research and development, manufacturing and sales of drugs, and sales of medical devices. Hanmi aims to develop and produce innovative and high-quality products to improve people's health worldwide. In the field of research and development, Hanmi Science is a leading company. It specializes in the research and development of novel drugs and biologics. The company has an impressive track record in the development and marketing of innovative drugs for the treatment of diabetes, cancer, and rare diseases. This includes a range of biosimilars produced using biotechnological methods that are more affordable compared to original medical substances. Hanmi also has a state-of-the-art production infrastructure that meets the highest quality standards and ensures reliable supply. In the field of drug manufacturing, the company produces generics and biosimilars that are sold in more than 50 countries worldwide. Hanmi also specializes in the production of chemotherapeutics and parenteral drugs that have proven efficacy and safety. The medical device sales division focuses on marketing high-quality medical devices, including diagnostic and monitoring devices used in the medical field. Hanmi also distributes a range of medical consumables, including transfusion sets, syringes, infusion sets, and catheters. Hanmi Science Co Ltd offers a wide range of products that can be categorized into various categories. Among the pharmaceutical products are antidiabetic drugs, anticancer agents, antidepressants, antibiotics, antiviral medications, and products for the treatment of rare diseases. The portfolio also includes biosimilars of botulinum toxin, insulin, and humiderm among the biologics. Overall, Hanmi Science Co Ltd holds a strong position in the South Korean market and has also established a good reputation internationally. With its focus on research and development and the production of high-quality drugs and medical devices, the company has a promising future. Hanmi Science Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Hanmi Science Co's Shares Outstanding

Hanmi Science Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Hanmi Science Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Hanmi Science Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Hanmi Science Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Hanmi Science Co stock

How many stocks are there of Hanmi Science Co?

The current number of stocks of Hanmi Science Co is 67.96 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Hanmi Science Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Hanmi Science Co evolved in recent years?

The number of shares of Hanmi Science Co has increased by -0.79% gesunken compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Hanmi Science Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Hanmi Science Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Hanmi Science Co pay?

Over the past 12 months, Hanmi Science Co paid a dividend of 200 KRW . This corresponds to a dividend yield of about 0.59 %. For the coming 12 months, Hanmi Science Co is expected to pay a dividend of 200 KRW.

What is the dividend yield of Hanmi Science Co?

The current dividend yield of Hanmi Science Co is 0.59 %.

When does Hanmi Science Co pay dividends?

Hanmi Science Co pays a quarterly dividend. This is distributed in the months of January, January, January, July.

How secure is the dividend of Hanmi Science Co?

Hanmi Science Co paid dividends every year for the past 7 years.

What is the dividend of Hanmi Science Co?

For the upcoming 12 months, dividends amounting to 200 KRW are expected. This corresponds to a dividend yield of 0.59 %.

In which sector is Hanmi Science Co located?

Hanmi Science Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hanmi Science Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hanmi Science Co from 8/14/2024 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Hanmi Science Co pay the last dividend?

The last dividend was paid out on 8/14/2024.

What was the dividend of Hanmi Science Co in the year 2023?

In the year 2023, Hanmi Science Co distributed 196.078 KRW as dividends.

In which currency does Hanmi Science Co pay out the dividend?

The dividends of Hanmi Science Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hanmi Science Co

Our stock analysis for Hanmi Science Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hanmi Science Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.